Sutro Biopharma
STRO
STRO
114 hedge funds and large institutions have $240M invested in Sutro Biopharma in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 108 → 114 (+6)
0.67% less ownership
Funds ownership: 92.34% → 91.67% (-0.67%)
Holders
114
Holding in Top 10
1
Calls
$7K
Puts
$5K
Top Buyers
| 1 | +$5.85M | |
| 2 | +$1.93M | |
| 3 | +$1.8M | |
| 4 |
Renaissance Technologies
New York
|
+$1.51M |
| 5 |
Two Sigma Investments
New York
|
+$1.39M |
Top Sellers
| 1 | -$8.06M | |
| 2 | -$7.4M | |
| 3 | -$2.75M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$2.71M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.06M |